Search results
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 1 day agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 6 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 6 days agoRecap of the Week’s Most Important Stories Lilly’s CFO Departs: Lilly’s executive vice president and...
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 3 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 2 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
Ongoing Efforts to Expand Kidney Donor Pool Seem Mostly Safe
Medscape· 1 day agoLiving donors had a similar risk for hypertension and albuminuria after donation as nondonors, and...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 19 hours agoEnthusiasm is growing for a looming approval in COPD treatment.
BlackRock Favoring Growth Heading Into Second Half
ETF Trends via Yahoo Finance· 6 days agoThe BlackRock Target Allocation Team, which runs model portfolios followed by many advisors, turned even more bullish this week. Indeed, the current...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 6 days agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...